Smoking, acute mountain sickness and altitude acclimatisation: a cohort study.
Détails
ID Serval
serval:BIB_3B7D1467A774
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Smoking, acute mountain sickness and altitude acclimatisation: a cohort study.
Périodique
Thorax
ISSN
1468-3296 (Electronic)
ISSN-L
0040-6376
Statut éditorial
Publié
Date de publication
2012
Volume
67
Numéro
10
Pages
914-919
Langue
anglais
Résumé
RATIONALE: The relationship between cigarette smoking and acute mountain sickness (AMS) is not clear.
OBJECTIVE: To assess AMS risk and altitude acclimatisation in relation to smoking.
METHODS: 200 healthy non-smokers and 182 cigarette smokers were recruited from Han lowland workers. These were men without prior altitude exposure, matched for age, health status and occupation, who were transported to an altitude of 4525 masl.
MEASUREMENTS: AMS, smoking habits, arterial saturation (SpO2), haemoglobin (Hb), lung function and mean pulmonary artery pressure (PAPm) were assessed upon arrival and after 3 and 6 months.
MAIN RESULTS: Compared with non-smokers, smokers had a lower incidence of AMS and lower AMS scores than non-smokers upon arrival; higher Hb and PAPm associated with lower SpO2 at 3 and 6 months at altitude; and lower forced expiratory volume in 1 s and maximal voluntary ventilation at 3 and 6 months.
CONCLUSIONS: Smoking slightly decreases the risk of AMS but impairs long-term altitude acclimatisation and lung function during a prolonged stay at high altitude.
OBJECTIVE: To assess AMS risk and altitude acclimatisation in relation to smoking.
METHODS: 200 healthy non-smokers and 182 cigarette smokers were recruited from Han lowland workers. These were men without prior altitude exposure, matched for age, health status and occupation, who were transported to an altitude of 4525 masl.
MEASUREMENTS: AMS, smoking habits, arterial saturation (SpO2), haemoglobin (Hb), lung function and mean pulmonary artery pressure (PAPm) were assessed upon arrival and after 3 and 6 months.
MAIN RESULTS: Compared with non-smokers, smokers had a lower incidence of AMS and lower AMS scores than non-smokers upon arrival; higher Hb and PAPm associated with lower SpO2 at 3 and 6 months at altitude; and lower forced expiratory volume in 1 s and maximal voluntary ventilation at 3 and 6 months.
CONCLUSIONS: Smoking slightly decreases the risk of AMS but impairs long-term altitude acclimatisation and lung function during a prolonged stay at high altitude.
Mots-clé
Acclimatization/physiology, Adult, Altitude Sickness/physiopathology, Chi-Square Distribution, China, Cohort Studies, Female, Humans, Logistic Models, Male, Middle Aged, Oxygen Consumption/physiology, Pulmonary Artery/physiology, Respiratory Function Tests, Risk Factors, Smoking/physiopathology
Pubmed
Web of science
Open Access
Oui
Création de la notice
25/09/2013 12:30
Dernière modification de la notice
20/08/2019 13:31